Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 20:2018:4528148.
doi: 10.1155/2018/4528148. eCollection 2018.

Right Ventricle Remodeling and Function in Scleroderma Patients

Affiliations
Review

Right Ventricle Remodeling and Function in Scleroderma Patients

Roxana Cucuruzac et al. Biomed Res Int. .

Abstract

Scleroderma, known also as systemic sclerosis (SSc), is a severe disease associated with high mortality rates, and right ventricular (RV) remodeling and dysfunction, along with pulmonary artery hypertension (PAH), are among the most important internal organ manifestations of this disease. PAH has a higher prevalence in patients with SSc compared to the general population and represents a significant predictor of mortality in SSc. In patients with SSc, the morphological remodeling and alteration of RV function begin even before the setting of PAH and lead to development of a specific adaptive pattern of the RV which is different from the one recorded in patients with IAPH. These alterations cause worse outcomes and increased mortality rates in SSc patients. Early detection of RV dysfunction and remodeling is possible using modern imaging tools currently available and can indicate the initiation of specific therapeutic measures before installation of PAH. The aim of this review is to summarize the current knowledge related to mechanisms involved in the remodeling and functional alteration of the RV in SSc patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The complex interrelation between the mechanisms involved in development of RV dysfunction and remodeling.

References

    1. Tedford R. J., Mudd J. O., Girgis R. E., et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circulation: Heart Failure. 2013;6(5):953–963. doi: 10.1161/CIRCHEARTFAILURE.112.000008. - DOI - PMC - PubMed
    1. Chung L., Farber H. W., Benza R., et al. Unique Predictors of Mortality in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in the REVEAL Registry. CHEST. 2014;146(6):1494–1504. doi: 10.1378/chest.13-3014. - DOI - PMC - PubMed
    1. Winstone T. A., Assayag D., Wilcox P. G., et al. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: A systematic review. CHEST. 2014;146(2):422–436. doi: 10.1378/chest.13-2626. - DOI - PubMed
    1. Elhai M., Meune C., Boubaya M., et al. Mapping and predicting mortality from systemic sclerosis. Annals of the Rheumatic Diseases. 2017 - PubMed
    1. Romanowska-Próchnicka K., Walczyk M., Olesińska M. Recognizing systemic sclerosis: Comparative analysis of various sets of classification criteria. Reumatología Clínica. 2016;54(6):296–305. doi: 10.5114/reum.2016.64906. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources